FrancophonIA/ELRC3.0 huggingface dataset:
English: In view of the significance of the findings of the ERA 223 clinical trial, it was considered that they should be thoroughly reviewed in the context of all available data related to radium-223 dichloride (including evidence from non-authorised use that might impact the authorised use) in order to assess their potential impact on the benefit-risk balance of Xofigo in the authorised indication of the treatment of adults with castration-resistant prostate cancer, symptomatic bone metastases and no known visceral metastases.
Maltese: Fid-dawl tas-sinifikat tas-sejbiet tal-prova klinika ERA 223, tqies li għandhom jiġu eżaminati bir-reqqa fil-kuntest tad-data kollha disponibbli relatata ma' radium Ra223 dichloride (inkluż evidenza minn użu mhux awtorizzat li jista' jkollu impatt fuq l-użu awtorizzat) sabiex jiġi evalwat l-impatt potenzjali tagħhom fuq il-bilanċ bejn il-benefiċċju u r-riskju ta' Xofigo fl-indikazzjoni awtorizzata tat-trattament ta' adulti b'kanċer tal-prostata reżistenti għall-kastrazzjoni, metastasi sintomatika fl-għadam u l-ebda metastasi vixxerali magħrufa.
English: The current recommendation relates only to provisional measures recommended by the PRAC for radium-223 dichloride based on the preliminary data available at this time.
Maltese: Ir-rakkomandazzjoni attwali hija relatata biss ma' miżuri provviżorji rakkomandati mill-PRAC għal radium Ra223 dichloride abbażi tad-data preliminari disponibbli bħalissa.
English: Based on the available data, Study 15396 shows that in chemotherapy-naïve asymptomatic or mildly symptomatic patients with CRPC, radium-223 in combination with concurrent abiraterone acetate and prednisolone/prednisone decreases overall survival and increases the risk of fractures compared to placebo in combination with abiraterone acetate and prednisone/prednisolone.
Maltese: Ibbażat fuq id-data disponibbli, Studju 15396 juri li f'pazjenti mhux sintomatiċi jew ftit sintomatiċi u li qatt ma ħadu kimoterapija qabel b'CRPC, radium-223 flimkien ma' abiraterone acetate fl-istess ħin u prednisolone/prednisone jnaqqas is-sopravivenza totali u jżid ir-riskju ta' ksur meta mqabbel ma'
English: The PRAC also noted that data available show that radium Ra223 dichloride is used to some extent in clinical practice in combination with anti-androgens such as abiraterone and enzalutamide.
Maltese: Il-PRAC innota wkoll li d-data disponibbli turi li r-radium Ra223 dichloride jintuża sa ċertu punt fil-prattika klinika flimkien ma' anti-androġeni bħal abiraterone u enzalutamide.
English: On 30 November 2017 the EC therefore triggered a procedure under Article 20 of Regulation (EC) No 726/2004 resulting from pharmacovigilance data, and requested the PRAC to assess the impact of the above concerns on the benefit-risk balance of Xofigo and to issue a recommendation on whether the marketing authorisation of this product should be maintained, varied, suspended or revoked.
Maltese: Għalhekk fit-30 ta' Novembru 2017, il-KE tat bidu għal proċedura skont l-Artikolu 20 tarRegolament (KE) Nru 726/2004 bħala riżultat ta' data dwar il-farmakoviġilanza, u talbet lill-PRAC jevalwa l-impatt tat-tħassib imsemmi hawn fuq dwar il-bilanċ bejn il-benefiċċju u r-riskju ta' Xofigo u biex joħroġ rakkomandazzjoni dwar jekk l-awtorizzazzjoni għat-tqegħid fis-suq għandhiex tinżamm, tiġi varjata, sospiża jew revokata.
English: The PRAC also considered other available data, including further data from the ALSYMPCA clinical trial submitted in support of the initial marketing authorisation, in relation to the potential impact of results of Study ERA 223 on the benefit-risk balance of radium Ra223 dichloride in its authorised indication.
Maltese: Il-PRAC ikkunsidra wkoll data oħra disponibbli, inkluża data oħra mill-prova klinika ALSYMPCA sottomessa b'appoġġ għall-awtorizzazzjoni inizjali għat-tqegħid fis-suq, b'rabta mal-impatt potenzjali tarriżultati tal-Istudju ERA 223 dwar il-bilanċ bejn il-benefiċċjuu r-riskju tad-radium Ra223 dichloride fl-indikazzjoni awtorizzata tiegħu.
English: The clinical efficacy of radium-223 dichloride in the authorised indication was established during the initial marketing authorisation application based on the assessment of data from one pivotal phase III study (15245/BC1-06, ALSYMPCA), in which an improved overall survival and delayed symptomatic skeletal events were observed.
Maltese: III (15245/BC1-06, ALSYMPCA), fejn ġiet osservata kemm sopravivenza globali mtejba kif ukoll avvenimenti skeletriċi sintomatiċi mdewma.
English: Healthcare professionals should be informed of the increased incidence of fractures and deaths among patients receiving Xofigo in combination with abiraterone acetate and prednisone/prednisolone compared to patients receiving placebo in combination with abiraterone acetate and prednisone/prednisolone in Study ERA-223, and of the reduced incidence of fractures observed in both treatment arms with concurrent use of bisphosphonates or denosumab bone health agents.
Maltese: Il-professjonisti tal-kura tas-saħħa għandhom ikunu infurmati dwar iż-żieda fl-inċidenza ta' fratturi u mwiet fost pazjenti li kienu qed jirċievu Xofigo flimkien ma' abiraterone acetate u prednisone/prednisolone meta mqabbla ma' pazjenti li kienu qed jirċievu plaċebo flimkien ma' abiraterone acetate u prednisone/prednisolone fi Studju ERA-223, u ta' inċidenza mnaqqsa ta' ksur osservat fiż-żewġ fergħat tat-trattament bl-użu konkorrenti ta' bisfosfonati jew aġenti tas-saħħa tal-għadam denosumab
English: EMA/760389/2014 EMEA/H/C/002835
Maltese: EMEA/H/C/002835
English: Average starting HbA1c was 8.3%, and this fell to below 7% in 48.8% of those given Abasaglar, and 52.5% of those given Lantus, with an average percentage point fall of 1.29 and 1.34 respectively.
Maltese: Il-medja tal-bidu HbA1c kienet 8.3%, u din naqset għal taħt 7% f'48.8% ta' dawk li ngħataw Abasaglar, u 52.5% ta' dawk li ngħataw Lantus, bi tnaqqis f'punti perċentwali medji ta' 1.29 u 1.34 rispettivament.
English: Their average HbA1c before treatment was 7.8% and the average fall after 6 months was similar (0.35% in the Abasaglar group and 0.46% in the Lantus group); 34.5% of those given Abasaglar, and 32.2% of those given Lantus were below the target of 7%.
Maltese: Il-medja ta' HbA1c tagħhom qabel il-kura kienet 7.8% u t-tnaqqis medju wara 6 xhur kien simili (0.35% fil-grupp ta' Abasaglar u 0.46% fil-grupp ta' Lantus); 34.5% ta' dawk li ngħataw Abasaglar, u 32.2% ta' dawk li ngħataw Lantus kienu taħt ilmira ta' 7%.
English: The full EPAR and risk management plan summary for Abasaglar can be found on the Agency's website: ema.europa.eu/Find medicine/Human medicines/European public assessment reports.
Maltese: ema.europa.eu/Find medicine/Human medicines/European public assessment reports.
English: Abasaglar is a ‘biosimilar medicine'.
Maltese: Abasaglar huwa ‘mediċina bijosimili'.
English: Insulin glargine is slightly different from human insulin.
Maltese: L-insulina glargina hija ftit differenti mill-insulina umana.
English: Other information about Abasaglar
Maltese: Informazzjoni oħra dwar Abasaglar
English: Abasaglar is a medicine that contains the active substance insulin glargine.
Maltese: Abasaglar huwa mediċna li fiha s-sustanza attiva insulina glargina.
English: The active substance in Abasaglar, insulin glargine, is produced by a method known as ‘recombinant DNA technology': it is made by bacteria into which a gene (DNA) has been introduced that makes them able to produce insulin glargine.
Maltese: Is-sustanza attiva f'Abasaglar, l-insulina glargina, tiġi prodotta b'metodu magħruf bħala ‘teknoloġija tad-DNA rikombinanti': hija magħmula minn batterji li fihom jiġi introdott ġene (DNA) li jagħmilhom kapaċi jipproduċu l-insulina glargina.
English: The reference medicine for Abasaglar is Lantus.
Maltese: Ilmediċina ta' referenza għal Abasaglar hija Lantus.
English: This is a summary of the European public assessment report (EPAR) for Abasaglar.
Maltese: Dan huwa sommarju tar-rapport pubbliku Ewropew ta' valutazzjoni (EPAR) għal Abasaglar.
English: Why is Abasaglar approved?
Maltese: Għaliex ġie approvat Abasaglar?
English: What are the risks associated with Abasaglar?
Maltese: X'inhuma r-riskji assoċjati ma' Abasaglar?
English: The European Commission granted a marketing authorisation valid throughout the European Union for Abasria on 9 September 2014.
Maltese: Il-Kummissjoni Ewropea tat awtorizzazzjoni għat-tqegħid fis-suq valida fl-Unjoni Ewropea kollha għal Abasria fil-09 ta' Settembru 2014.
English: For more information on biosimilar medicines, see the question-and-answer document here.
Maltese: Għal aktar informazzjoni dwar mediċini bijosimili, ara d-dokument ta' mistoqsijiet u tweġibiet hawn.
English: In addition, treatment with once-daily Abasaglar has been shown to be comparable to the reference medicine, Lantus, in two supportive studies involving a total of 1,295 adults with diabetes.
Maltese: Barra minn hekk, kura b'Abasaglar darba kuljum intweriet li hija komparabbli mal-mediċina ta' referenza, Lantus, f'żewġ studji ta' appoġġ li involvew total ta' 1,295 adult b'dijabete.
English: • In the second study, treatment with Abasaglar or Lantus was compared in 759 patients with type 2 diabetes, as an addition to diabetes medicines taken by mouth.
Maltese: • Fit-tieni studju, kura b'Abasaglar jew Lantus tqabblet f'759 pazjent b'dijabete tat-tip 2, bħala addizzjoni ma' mediċini kontra d-dijabete li jittieħdu mill-ħalq.
English: Reactions at the site of the injection (redness, pain, itching and swelling) and skin reactions (rash) have been seen more often in children than in adults.
Maltese: Reazzjonijiet fil-post tal-injezzjoni (ħmura, uġigħ, ħakk u nefħa) u reazzjonijiet tal-ġilda (raxx) dehru iktar ta' spiss fit-tfal milli fl-adulti.
English: • In one study, Abasaglar was compared with Lantus when added to short-acting insulin treatment in 536 patients with type 1 diabetes.
Maltese: • Fi studju wieħed, Abasaglar tqabbel ma' Lantus meta miżjud ma' kura tal-insulina li taġixxi għal żmien qasir f'536 pazjent b'dijabete tat-tip 1.
English: Abasaglar is a replacement insulin that is very similar to the insulin made by the body.
Maltese: Abasaglar huwa insulina ta' sostituzzjoni li hija simili ħafna għall-insulina magħmula millġisem.
English: Previously known as Abasria
Maltese: Kif jintuża Abasaglar?
English: This means that Abasaglar is similar to a biological medicine (also known as the ‘reference medicine') that is already authorised in the European Union (EU).
Maltese: Dan ifisser li Abrasia huwa simili għal mediċina bijoloġika (magħrufa wkoll bħala l-‘mediċina ta' referenza') li diġà ġiet awtorizzata fl-Unjoni Ewropea (UE).
English: A risk management plan has been developed to ensure that Abasaglar is used as safely as possible.
Maltese: Ġie żviluppat pjan ta' ġestjoni tar-riskju biex jiġi żgurat li Abasaglar jintuża bl-aktar mod sigur possibbli.
English: It is given by injection under the skin in the abdominal wall (tummy), the thigh, or the deltoid region (upper arm).
Maltese: Jingħata b'injezzjoni taħt il-ġilda fil-ħajt addominali (żaqq), il-koxxa, jew fir-reġjun deltojde (parti ta' fuq tad-driegħ).
English: The Agency's Committee for Medicinal Products for Human Use (CHMP) decided that, in accordance with EU requirements for biosimilar medicines, Abasaglar has been shown to have a comparable quality, safety and effectiveness to Lantus.
Maltese: Il-Kumitat għall-Prodotti Mediċinali għall-Użu mill-Bniedem (CHMP) tal-Aġenzija ddeċieda li, b'mod konformi mar-rekwiżiti tal-UE għal mediċini bijosimili, Abasaglar wera li għandu profil ta' kwalità, sigurtà u effikaċja komparabbli ma' Lantus.
English: The most common side effect with Abasaglar (which may affect more than 1 in 10 people) is hypoglycaemia (low blood glucose).
Maltese: L-effett sekondarju l-aktar komuni b'Abasaglar (li jista' jaffettwa aktar minn 1 minn kull 10) huwa ipogliċemija (glukożju baxx fid-demm).
English: How is Abasaglar used?
Maltese: Kif jaħdem Abasaglar?
English: The name of the medicine was changed to Abasaglar on 3 December
Maltese: L-isem tal-mediċina nbidel f'Abasaglar Fit-3 ta' Diċembru 2014.
English: insulin glargine
Maltese: Sommarju tal-EPAR għall-pubbliku insulina glargina
English: In both studies, the main measure of effectiveness was the change after 6 months of treatment in the level in the blood of a substance called glycosylated haemoglobin (HbA1c), which gives an indication of how well blood glucose is controlled.
Maltese: Billi tikkontrolla l-livelli ta' glukożju fid-demm, is-sintomi u lkumplikazzjonijiet tad-dijabete jitnaqqsu.
English: For the full list of all side effects and restrictions with Abasaglar, see the package leaflet.
Maltese: Għal-lista sħiħa taleffetti sekondarji u restrizzjonijiet b'Abasaglar, ara l-fuljett ta' tagħrif.
English: The dose is adjusted individually, and the patient's blood glucose (sugar) should be regularly tested to find the lowest effective dose.
Maltese: Id-doża tiġi aġġustata individwalment, u l-glukożju (zokkor) fid-demm tal-pazjent għandu jiġi ttestjat regolarment biex tinstab id-doża effettiva l-iktar baxxa.
English: The replacement insulin acts in same way as naturally produced insulin and helps glucose enter cells from the blood.
Maltese: L-insulina ta' sostituzzjoni taħdem bl-istess mod bħal insulina prodotta b'mod naturali u tgħin lill-glukożju jidħol fiċ-ċelloli mid-demm.
English: URGO SOINS & SANTÉ
Maltese: URGO SOINS &
English: Barcelona, Spain
Maltese: Barcelona, Spanja
English: 75001 Paris France
Maltese: 75001 Paris Franza
English: INTERNACIONAL, S.A. Gran Via Carlos III, 94 Barcelona, Spain
Maltese: INTERNACIONAL, S.A. Gran Via Carlos III, 94 Barcelona,
English: 08960 Sant Just Desvern (Barcelona) Spain
Maltese: 08960 Sant Just Desvern (Barcelona)
English: 00101 Helsinki, Finland
Maltese: 00101 Helsinki,
English: 30,500 28802 Alcalá de Henares (Madrid) Spain
Maltese: 30,500 28802 Alcalá de Henares (Madrid)
English: 37 avenue Gabriel PériB.P.
Maltese: AMIDO 37 avenue Gabriel PériB.P.
English: HEXAPNEUMI NE
Maltese: HEXAPNEUMIN E
English: S.E.R.P (Société d'Etudes et de Recherches Pharmaceutiques) 5, rue du Gabian Immeuble "Le triton" 98000 Monaco France
Maltese: S.E.R.P (Société d'Etudes et de Recherches Pharmaceutiques) 5, rue du Gabian Immeuble "Le triton" 98000 Monaco Franza
English: RECTAGMIGD OL INFANTIL
Maltese: RECTAGMIGDO L INFANTIL
English: ESCANED C/ Tomás Bretón, 46 28045 Madrid, Spain
Maltese: ESCANED C/ Tomás Bretón, 46 28045
English: 42, rue de Longvic BP157
Maltese: SANTÉ 42, rue de Longvic BP157
English: LABORATOIRE HEPATOUM 1 rue de Plaisance 94130 Nogent-surMarne
Maltese: LABORATOIRE HEPATOUM 1 rue de Plaisance 94130
English: 13718 Allauch France
Maltese: 13718 Allauch Franza
English: Bismuth camphocarbonat e
Maltese: bismuth camphocarbonate
English: 181-183 rue André Karman
Maltese: 181-183 rue André Karman BP101
English: Hädensa ichthammolum, mentholum ichthammolum 4 mg, mentholum 50 mg
Maltese: Hädensa ichthammolum, mentholum ichthammolu m 4 mg, mentholum 50 mg
English: Cineole + Camphor + Gomenol (Niaouli oil)
Maltese: cineole + gamfra + gomenol (niaouli oil)
English: Belgium Medgenix benelux NV Vliegveld 21
Maltese: Medgenix benelux NV Vliegveld 21
English: SPINDLER 6, Avenue de l'Europe BP51
Maltese: 6, Avenue de l'Europe BP51
English: SOBREPIN SUPOSITORIO S INFANTIL
Maltese: SOBREPIN SUPOSITORIOS INFANTIL
English: Teofarma Srl Via F.lli Cervi, 8 27010 Pavia, Italy
Maltese: Teofarma Srl Via F.lli Cervi, 8 27010
English: LABORATOIRES GENEVRIER SA 280 rue de Goa Les trois MoulinsParc de Sophia Antipolis
Maltese: LABORATOIRES GENEVRIER SA 280 rue de Goa Les trois Moulins - Parc de Sophia Antipolis 06600 Antibes Franza
English: MEDICATION FAMILIALE SAS 37 rue Saint-Romain 69379 Lyon Cedex 08 France
Maltese: MERCK MEDICATION FAMILIALE SAS 37 rue Saint-Romain 69379 Lyon Cedex 08 Franza
English: BROTA RECTAL SUPOSITORIO S
Maltese: BROTA RECTAL SUPOSITORIOS
English: 78401 Chatou Cedex France
Maltese: 78401 Chatou Cedex Franza
English: BI-QUI-NOL ENFANTS, suppositoire camphre racémique, cinéole
Maltese: BI-QUI-NOL ENFANTS, suppositoire gamfra racémique, cineole
English: Luxembourg Medgenix benelux NV Vliegveld 21
Maltese: Il-Lussemburgu Medgenix benelux NV Vliegveld 21
English: ZAMBON FRANCE 13 rue René Jacques 92138 Issy-lesMoulineaux Cedex France
Maltese: ZAMBON FRANCE 13 rue René Jacques 92138 Issy-les-Moulineaux Cedex
English: 1C, Culliganlaan B-1831 Diegem
Maltese: B-1831 Diegem
English: 21304 Chenove Cedex France calmosedyl
Maltese: 21304 Chenove Cedex Franza calmosedyl
English: COOPERATION PHARMACEUTIQUE FRANCAISE Place Lucien Auvert 77020 Melun Cedex France
Maltese: COOPERATION PHARMACEUTIQUE FRANCAISE Place Lucien Auvert 77020
English: 93303 Aubervilliers Cedex
Maltese: 93303 Aubervilliers Cedex Franza
English: OZOTHINE A LA
Maltese: BIOCALYPTOL A LA
English: Meda PharmaProdutos farmacêuticos, S.A. Rua do Centro Cultural, 13 1749-066 Lisboa
Maltese: Rua do Centro Cultural, 13 1749066 Lisboa
English: LABORATOIRES JOLLY JATEL 28 avenue Carnot 78951 Saint-Germain en Laye Cedex France
Maltese: 28 avenue Carnot 78951 Saint-Germain en Laye Cedex
English: LABORATOIRES MAYOLY
Maltese: LABORATOIRES JOLLY JATEL
English: CAMPHOCAL YPTOL SIMPLE ENFANTS 0,07 g, suppositoire
Maltese: CAMPHOCALYP TOL SIMPLE ENFANTS 0,07 g, suppositoire
English: Pont Reixat, 5
Maltese: DIVISER AQUILEA S.L. Pont Reixat, 5
English: DIMINEX ANTITUSIGEN O
Maltese: DIMINEX ANTITUSIGENO SUPOSITORIOS
English: Oy Leiras Finland Ab, Paciuksenkatu 21 PL 1406,
Maltese: Il-Finlandja Oy Leiras Finland Ab, Paciuksenkatu 21
English: Camphor + Eucalyptol + Menthol
Maltese: gamfra + eucalyptol + mentol
English: Geymonat Spa Via S. Anna, 2 03012 Anagni (FR), Italy
Maltese: Anna, 2 03012 Anagni (FR), Italy
English: BE-8500 Wevelgem Belgium
Maltese: BE-8500
English: EucalyptinePholcodine Enfants camphre eucalyptol gaiacol phenol pholcodine
Maltese: EucalyptinePholcodine Enfants gamfra eucalyptol gaiacol phenol pholcodine
English: CAMPHOCAL YPTOL SIMPLE NOURRISSON S 0,06 g, suppositoire
Maltese: CAMPHOCALYP TOL SIMPLE NOURRISSONS 0,06 g, suppositoire
English: Trophires Compose Nourrissons paracetamol essence d'eucalyptus tenoate de sodium
Maltese: Trophires Compose Nourrissons paracetamol żejt essenzjali talewkaliptu tenoate de sodium
English: Eucalyptine Lebrun eucalyptol inn:codéine phosphate
Maltese: Eucalyptine Lebrun eucalyptol codéine phosphate
English: BRONCHOREC TINE AU CITRAL ENFANTS, suppositoire terpinol, pin, serpolet
Maltese: BRONCHORECTI NE AU CITRAL ENFANTS, suppositoire terpineol, arżnu, serpolet
English: Luxembourg Sanofi-Aventis Belgium
Maltese: Il-Lussemburgu Sanofi-Aventis Belgium 1C, Culliganlaan
English: Trophires Enfants eucalyptus huile essentielle thiophene carboxylate paracetamo
Maltese: Trophires Enfants żejt essenzjali talewkaliptu thiophene carboxylate paracetamol
English: eucalyptus huile essentielle thiophene carboxylate paracetamo
Maltese: żejt essenzjali talewkaliptu thiophene carboxylate paracetamol
English: 40 mg (eucalyptol) 2 mg (guaiacol)
Maltese: 2 mg (guaiacol)
English: BRONCHOREC TINE AU CITRAL NOURRISSON S, suppositoire terpinol, pin, serpolet
Maltese: BRONCHORECTI NE AU CITRAL NOURRISSONS, suppositoire terpineol, arżnu, serpolet
English: FEBRECTOL NOURRISSON S, suppositoire pin
Maltese: FEBRECTOL NOURRISSONS, suppositoire arżnu
English: EUCALYPTIN E LE BRUN NOURRISSON S, suppositoire
Maltese: EUCALYPTINE LE BRUN NOURRISSONS, suppositoire
English: OZOTHINE ENFANTS 30 mg, suppositoire terebenthine (huile essentielle de)
Maltese: OZOTHINE ENFANTS 30 mg, suppositoire żejt essenzjali tat 0,03g
English: 1-13 boulevard Romain Rolland 75014 Paris France
Maltese: AVENTIS France 1-13 boulevard Romain Rolland
English: HEXAPNEUMI NE ENFANTS, suppositoire
Maltese: HEXAPNEUMIN E ENFANTS, suppositoire
English: SUPOSITORIO S
Maltese: PILKA SUPOSITORIOS
English: FEBRECTOL ENFANTS, suppositoire pin
Maltese: FEBRECTOL ENFANTS, suppositoire arżnu
English: PILKA
Maltese: Il
English: NOURRISSON S, suppositoire
Maltese: NOURRISSONS, suppositoire
English: BOUCHARA RECORDATI 38 rue MarjolinBP67
Maltese: BOUCHARA RECORDATI 38 rue Marjolin - BP67 92302 Levallois-Perret Cedex Franza
English: Eucalyptine Pholcodine Child camphora inn:eucalyptol inn:guaiacol inn:pholcodine inn:phenol
Maltese: Eucalyptine Pholcodine Child gamfra eucalyptol guaiacol pholcodine phenol
English: EUCALYPTOS PIRINE ENFANTS, suppositoire
Maltese: EUCALYPTINE ENFANTS, suppositoire
English: TERPONE ENFANTS, suppositoire niaouli, huile essentielle d'eucalyptus, terpine, huile essentielle d'aiguilles de pin de siberie
Maltese: TERPONE ENFANTS, suppositoire niaouli, żejt essenzjali talewkaliptu, terpine, żejt essenzjali talarżnu
English: BRONCHODE RMINE ENFANTS, suppositoire cinéole, huile essentielle de pin
Maltese: BRONCHODERM INE ENFANTS, suppositoire cineole, żejt essenzjali talarżnu
English: Trophires Bebes eucalyptus huile essentielle tenuate de sodium
Maltese: Trophires Bebes żejt essenzjali talewkaliptu tenuate de sodium
English: TROPHIRES NOURRISSON S, suppositoire huile essentielle d'eucalyptus
Maltese: TROPHIRES NOURRISSONS, suppositoire żejt essenzjali tal 0,044g
English: TERPONE NOURRISSON S, suppositoire niaouli, huile essentielle d'eucalyptus, terpine, huile essentielle d'aiguilles de pin de siberie
Maltese: TERPONE NOURRISSONS, suppositoire niaouli, żejt essenzjali talewkaliptu s, terpine, żejt essenzjali talarżnu
English: Cineole
Maltese: Wevelgem
English: TROPHIRES COMPOSE NOURRISSON S, suppositoire huile essentielle d'eucalyptus
Maltese: TROPHIRES COMPOSE NOURRISSONS, suppositoire żejt essenzjali tal 0,044g
English: Belgium
Maltese: Paris
English: SANOFI AVENTIS France
Maltese: Nogent-sur-Marne Franza
English: Eucalyptine camphora inn:eucalyptol inn:guaiacol
Maltese: Eucalyptine gamfra eucalyptol guaiacol
English: TROPHIRES COMPOSE ENFANTS, suppositoire huile essentielle d'eucalyptus
Maltese: TROPHIRES COMPOSE ENFANTS, suppositoire żejt essenzjali tal 0,075g
English: TROPHIRES ENFANTS, suppositoire huile essentielle d'eucalyptus
Maltese: TROPHIRES ENFANTS, suppositoire żejt essenzjali tal 0,075g
English: Ozopulmin Oxidation product of turpentine/pine essential oil
Maltese: Ozopulmin prodott ta' ossidazzjoni tatterpentina/ żejt essenzjali talarżnu
English: DIVISER AQUILEA S.L.
Maltese: Geymonat Spa Via S.
English: BRONCHODE RMINE NOURRISSON S, suppositoire cinéole, huile essentielle de pin
Maltese: NOURRISSONS, suppositoire cineole, żejt essenzjali talarżnu
English: Overall Population (n=237)
Maltese: Popolazzjoni Globali (n=237)
English: Follow-Up (day)
Maltese: Follow-Up (jum)
English: ATC code: V03AE09
Maltese: V03AE09
English: 5.1 to <5.5 mEq/L (n=90)
Maltese: 5.1 sa < 5.5 mEq/L (n=90)
English: 92042 Paris La Défense Cedex France
Maltese: 92042 Paris La Défense Cedex
English: Information about sorbitol
Maltese: Informazzjoni dwar sorbitol
English: In vitro studies have shown potential interaction of patiromer with quinidine.
Maltese: Studji in vitro wrew interazzjoni potenzjali ta' patiromer ma' quinidine.
English: OM Pharma S.A. R. da Indústria, 2 Quinta Grande Amadora, 2610-088 Portugal
Maltese: Quinta Grande Amadora, 2610-088 Il-Portugall
English: In vitro studies have shown no potential interaction of patiromer with the following active substances: allopurinol, amoxicillin, apixaban, acetylsalicylic acid, atorvastatin, cephalexin, digoxin, glipizide, lisinopril, phenytoin, riboflavin, rivaroxaban, spironolactone and valsartan.
Maltese: Studji in vitro ma wrew l-ebda interazzjoni potenzjali ta' patiromer mas-sustanzi attivi li ġejjin: allopurinol, amoxicillin, apixaban, acetylsalicylic acid, atorvastatin, cephalexin, digoxin, glipizide, lisinopril, phenytoin, riboflavin, rivaroxaban, spironolactone u valsartan.
English: 60 sachets
Maltese: 60 qartas
English: powder for oral suspension 30 sachets
Maltese: trab għal suspensjoni orali 30 qartas
English: • ciprofloxacin: a medicine to treat bacterial infections
Maltese: • ciprofloxacin: mediċina għall-kura ta' infezzjonijiet batterjali
English: Gastrointestinal disorders
Maltese: Disturbi Gastrointestinali
English: INFORMATION IN BRAILLE VELTASSA 25.2 G
Maltese: INFORMAZZJONI BIL-BRAILLE VELTASSA 25.2 G
English: • levothyroxine: a medicine to treat thyroid hormone deficiency
Maltese: • levothyroxine: mediċina għall-kura ta' defiċjenza ta' ormoni tat-tirojde